Gene One Life Science Delays Share Placement Payment to Nov. 26 Amid US Litigation

Bitget2026/10/23 07:51

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Gene One Life Science postponed payment for its KRW 15 billion private placement to Nov. 26, 2026, from Oct. 23.
Revolt Investment Partnership requested the delay to review the company's legal response to a US default judgment involving Inovio.
The company is seeking to vacate the judgment on procedural and substantive grounds.
New-share delivery and listing were rescheduled to Dec. 10, 2026, from Nov. 6.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Gene One Life Science Inc. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261023000364), on October 23, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Gene One Life Science Delays Share Placement Payment to Nov. 26 Amid US Litigation

You may also like

Crypto prices